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Abstract
INTRODUCTION
Randomised	 controlled	 trials	 are	 prospective	 studies	 that	
measure	the	effectiveness	of	a	new	intervention	or	treatment.	
The	act	of	randomisation	balances	observed	and	unobserved	
characteristics	 between	 intervention	 and	 control	 groups	
allowing	any	differences	 in	outcome	 to	be	attributed	 to	 the	
intervention.[1]	The	number	of	participants	required	to	detect	
effectiveness	(sample	size)	is	calculated.	Minimising	bias	is	a	
key	concept	in	the	randomised	controlled	trial	design,	achieved	
through	 concealment	 of	 the	 random	 assignment	 to	 each	
intervention	group,	and	blinding	or	masking	of	participants,	
professionals	or	outcome	assessors	to	the	intervention	being	
received.[1]	There	 has	 been	 an	 increase	 in	 the	 number	 of	
randomised	controlled	trials	in	aphasia,	from	30	trials	included	
in	a	Cochrane	review	of	speech	and	language	therapy	in	stroke	
in	2010,	to	57	in	2016.[2,3]	Many	RCTs	in	the	ield	use	small	
numbers	without	a	priori	sample	size	calculations	to	ensure	
they	 are	 adequately	powered	 to	 detect	 an	 effect.	However,	
there	 have	been	 a	 growing	number	 of	 adequately	powered	
multicentre	RCTs	 conducted	 in	 aphasia	more	 recently.[4-9]	
Consequently	 there	 is	 increasing	insight	 into	what	needs	 to	
be	considered	before	embarking	on	a	large	trial	of	a	complex	
intervention	for	people	with	aphasia.	One	such	trial	was	the	
multicentre	Big	CACTUS	RCT	 of	 computerised	 aphasia	
therapy	 in	 21	 speech	 and	 language	 therapy	departments	 in	
the	UK,	 [ISRCTN68798818].[6]	As	 amounts	 of	 speech	 and	
language	therapy	offered	in	the	longer	term	post-stroke	can	be	
limited,[10]	and	people	with	aphasia	often	want	more	therapy	
than	 is	 available	 face	 to	 face,[11]	 the	Big	CACTUS	 study	
evaluated	the	effectiveness	and	cost-effectiveness	of	offering	
self-managed	word	inding	practice	using	specialist	aphasia	
computer	software	(StepbyStep),[12]	tailored	by	a	speech	and	
language	therapist	(SLT)	and	supported	by	a	speech	therapy	
assistant	 or	 volunteer.[6,13]	This	 article	 outlines	 some	of	 the	
considerations	in	designing	an	RCT	for	aphasia	illustrated	with	
decisions	made	in	the	design	of	Big	CACTUS.
Do we need a trial?
Firstly,	it	is	important	to	consider	whether	an	RCT	is	needed	
and	if	it	is	the	best	design	to	answer	the	research	question.	This	
is	particularly	important	given	the	associated	time	and	costs	of	
completing	an	RCT,	which	can	be	particularly	high	for	trials	in	
The	use	of	the	randomised	controlled	trial	(RCT)	design	to	evaluate	the	effectiveness	of	new	interventions	in	aphasia	has	increased	in	recent	
years	in	response	to	calls	for	high	quality	evidence	of	the	effectiveness	of	interventions	for	this	population.	This	view-point	article	highlights	
some	of	the	important	considerations	when	designing	a	trial	for	an	aphasia	intervention,	illustrated	with	decisions	made	when	designing	the	
Big	CACTUS	RCT	for	self-managed	computer-based	word	inding	therapy	in	aphasia.	Considerations	outlined	include	whether	an	RCT	is	
needed,	readiness	for	conducting	an	RCT,	choice	of	comparators,	randomisation	options,	blinding/masking,	selection	of	outcome	measures,	
pragmatic	versus	explanatory	approaches,	and	idelity	measurement.
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aphasia	due	to	the	face	to	face	and	specialist	communication	
support	 requirements	 of	 providing	 informed	 consent	 and	
completing	outcome	measures.	An	RCT	design	is	appropriate	
to	answer	questions	about	the	effectiveness	of	an	intervention	
where	 there	 is	 uncertainty	 amongst	 the	 profession	 about	
whether	a	particular	aphasia	intervention	is	effective,	requiring	
evidence	to	support	its	implementation	or	its	decommissioning.	
The	Big	CACTUS	RCT	was	conducted	as	use	of	computers	
to	deliver	increased	amounts	of	SLT	is	a	growth	area	in	the	
SLT	profession,	yet	the	small	scale	of	existing	studies	leaves	
uncertainty	as	to	the	effectiveness	and	cost	effectiveness	of	
this	option.[14]	RCTs	are	also	often	used	to	assess	safety	of	new	
interventions.	The	extent	of	safety	considerations	is	likely	to	
vary	considerably	between	different	aphasia	interventions.	We	
considered	safety	in	Big	CACTUS	due	to	the	use	of	electrical	
equipment	and	regular	screen	use.[13]
Are we ready for a trial?
The	Medical	Research	Council	 (MRC)	 framework	 for	 the	
evaluation	 of	 complex	 interventions	 identiies	 four	 phases:	
development,	 feasibility,	 evaluation	 and	 implementation.[15]	
An	RCT	can	be	used	 at	 the	 evaluation	 stage	 to	 investigate	
effectiveness	of	an	aphasia	intervention.
Prior	to	evaluation,	it	is	important	to	develop	the	intervention	
based	on	 existing	 evidence	 in	 the	 literature,	 and	 co-design	
with	SLTs	and	people	with	aphasia,	keeping	in	mind	feasibility	
of	 implementing	 the	 intervention	 in	 practice.	We	 need	 to	
identify	the	intended	outcomes	and	mechanisms	by	which	the	
intervention	is	expected	to	achieve	these	outcomes.[16]	Before	
the	Big	CACTUS	trial	of	self-managed	aphasia	therapy	for	
word	inding	using	a	computer,	the	StepbyStep	word	inding	
software	 underwent	 iterative	 development	 and	 testing	with	
case	 series	 studies	 investigating	 the	 potential	 beneits	 for	
individuals.[12,17]	The	key	components	of	the	intervention	and	
how	they	were	expected	to	lead	to	improved	word	inding	were	
identiied	through	key	stakeholder	discussions.[18]
The	Stroke	Recovery	 and	Rehabilitation	Round	 table	 have	
recently	published	 a	 trial	 development	 framework	 to	guide	
decision	making	(Go,	No-go	criteria)	in	the	development	of	
trials	for	stroke	recovery.[19]	This	framework	will	be	useful	to	
guide	 the	planning	of	 future	 trials	 in	aphasia	and	 identiies	
important	 ‘knowledge	 units’	 for	which	 to	 understand	 the	
pre-clinical	 and	 clinical	 evidence	 when	 developing	 an	
intervention.	These	 knowledge	 units	 include:	 ‘How	much	
treatment?’,	‘What	are	the	active	ingredients	of	the	treatment?’,	
‘Who	 should	 be	 treated?’	 and	 ‘When	 is	 treatment	 best	
delivered?’.	If	such	knowledge	units	cannot	be	informed	by	
existing	literature,	the	framework	suggest	that	the	intervention	
is	 not	 yet	 ready	 to	 be	 trialled	 in	 an	RCT	 and	 additional	
preliminary	research	is	indicated.
The	feasibility	stage	of	the	MRC	framework	is	important	to	
become	ready	for	an	adequately	powered	RCT.	At	this	stage	
preparatory	work	can	be	conducted	to	investigate	whether	the	
intervention	is	acceptable	and	whether	it	can	be	delivered	in	a	
clinical	context.	Our	CACTUS	pilot	study	interviewed	people	
with	aphasia,	carers	and	volunteers	supporting	the	self-managed	
intervention	 to	gauge	acceptability	of	 the	 intervention.[20]	 In	
addition	to	feasibility	of	delivering	an	intervention,	it	is	also	
important	to	test	the	feasibility	of	running	a	trial	before	planning	
a	multicentre	RCT.	It	is	necessary	to	collect	data	on	whether	it	is	
possible	to	recruit	the	population	needed	for	the	trial,	indications	
of	recruitment	and	attrition	rates,	whether	randomisation	works	
and	is	acceptable,	and	whether	outcome	measures	are	useful	and	
acceptable.	A	pilot	trial	(CACTUS)	was	conducted	to	inform	
our	RCT	(Big	CACTUS).[21]	This	pilot	helped	further	develop	
the	 intervention	 protocol	 in	 terms	 of	 how	much	 computer	
practice	was	realistic	to	expect	people	with	aphasia	to	complete	
independently	at	home	and	it	informed	adaptions	required	to	
ensure	the	intervention	was	feasible	to	deliver	in	practice.	The	
pilot	also	identiied	that	people	with	very	severe	word	inding	
did	not	appear	to	derive	any	beneit	from	this	intervention	which	
shaped	the	patient	inclusion	criteria	for	the	following	RCT.	We	
identiied	a	clinically	meaningful	effect	size	for	change	in	word	
inding	ability	with	which	to	calculate	the	sample	size	for	the	
RCT,	and	this	was	inlated	by	the	attrition	rate	seen	in	the	pilot	
study	(15%).	We	also	found	we	were	able	to	recruit	at	a	rate	of	
one	participant	per	month	per	site.	This	information	together	
enabled	planning	for	suficient	recruitment	sites	–	20	sites	were	
required	 to	 recruit	 the	 sample	 size	of	 285	participants	with	
aphasia	over	15	months	each.[13]
What shall we compare the intervention to?
Comparison	is	a	core	element	of	the	RCT	design.	One	option	
is	 to	 compare	 to	 participants	 not	 having	 any	 intervention.	
This	 is	 dificult	 in	 speech	 and	 language	 therapy	given	 that	
people	 live	 in	 a	world	where	 communication	 is	 all	 around	
them	and	they	are	likely	to	be	receiving	language	stimulation	
to	some	extent	either	in	family	interactions	or	attendance	at	
support	groups.	Therefore,	 in	 the	CACTUS	pilot	 study,	we	
compared	computerised	aphasia	therapy	to	usual	stimulation,	
acknowledging	that	we	cannot	(and	would	not	want	to)	limit	
exposure	 to	 communication	 in	 daily	 life.[21]	 If	we	want	 to	
know	whether	 the	 intervention	 is	 superior	 to	what	 people	
with	aphasia	usually	receive,	it	can	be	compared	to	usual	care.	
If	 it	 is	envisaged	 that	 the	new	 intervention	would	be	given	
instead	of	usual	care,	it	can	be	compared	on	its	own	to	usual	
care.	In	the	Big	CACTUS	trial,	we	were	aiming	to	evaluate	
the	 effectiveness	 of	 providing	 self-managed	word	 inding	
therapy	on	a	computer	to	increase	the	amount	of	therapy	people	
had	access	to.	Consequently,	we	viewed	this	intervention	as	
something	that	would	be	provided	in	addition	to	usual	care	and	
not	instead	of	it.	Therefore,	we	made	the	decision	to	compare	
the	computer	therapy	plus	usual	care	to	usual	care	alone	using	
an	‘adjunct’	trial	design.
It	 is	 not	 uncommon	 to	 also	 compare	 new	 rehabilitation	
interventions	to	an	‘attention	control’	condition.	The	purpose	
of	 this	 is	 to	 differentiate	 the	 effect	 of	 the	 speciic	 therapy	
from	 the	 effect	 of	 attention	 from	a	professional.	 In	 speech	
and	 language	 therapy	 interventions	 for	 aphasia	 the	 idea	 of	
an	 attention	 control	 needs	 considerable	 thought.	 If	 using	
conversation	with	a	professional	or	volunteer	as	an	attention	
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control,	there	is	likely	to	be	some	overlap	between	the	language	
stimulation	of	conversation	and	the	stimulation	of	the	language	
therapy	components.[22]	In	Big	CACTUS,	an	attention	control	
group	was	 used	 to	 differentiate	 the	 effect	 of	 the	 language	
therapy	components	from	the	additional	support	received	from	
volunteers	during	the	intervention.	It	was	also	recognised	that	
attention	 is	 limited	during	 a	 self-managed	 intervention	 and	
consequently	we	also	controlled	for	the	self-managed	activity	
carried	out	in	the	Big	CACTUS	intervention.	Attention/activity	
control	participants	were	provided	with	puzzle	books	such	as	
Sudoku,	spot	the	difference,	colouring	activities	and	asked	to	
complete	one	activity	a	day	to	control	for	the	daily	activity	
being	conducted	on	the	computer	in	the	intervention	group.	
Books	were	tailored	to	participant’s	interests	and	updated	each	
month	in	terms	of	dificulty	in	keeping	with	the	tailoring	of	
language	exercises	that	happened	in	the	computer	intervention.	
The	 intervention	group	had	volunteers	or	SLT	assistants	 to	
provide	support	 for	 them	once	a	month.	To	control	 for	 this	
support,	the	attention/activity	control	group	received	monthly	
phone	calls	from	a	researcher	to	provide	general	support.[6]
Can we randomise?
Recruitment	to	a	trial	is	partly	contingent	upon	the	acceptability	
of	 randomisation	 to	 the	 participants.	 People	with	 aphasia	
often	do	not	receive	as	much	speech	and	language	therapy	as	
they	would	like	and	are	keen	to	try	new	treatment	approaches	
in	 research	 studies.	We	 understood	 that	 one	 driver	 for	
participation	 in	 the	Big	CACTUS	trial	was	 likely	 to	be	 the	
desire	to	try	self-managed	word	inding	therapy	on	a	computer.	
Indeed,	during	the	pilot	CACTUS	study	we	experienced	drop	
out	of	3	participants	because	they	did	not	get	randomised	to	
the	computer	group.	It	is	therefore	important	to	consider	ways	
of	mitigating	the	effects	of	randomisation	on	recruitment	and	
differential	 attrition	between	groups.	 In	Big	CACTUS,	we	
addressed	this	issue	by	explaining	the	randomisation	process	
in	participant	information	sheets,	along	with	an	offer	to	provide	
software	for	participants	to	have	a	go	with	after	the	trial,	if	
they	were	randomised	to	usual	care	or	attention	control.	Other	
aphasia	trials	have	addressed	the	implications	of	randomisation	
in	different	ways,	e.g.,	SUPERB	used	a	modiied	Zelen	design	
in	which	participants	consented	irst	 to	being	 involved	 in	a	
study	monitoring	adjustment	to	life	post	stroke,	but	not	told	
what	the	speciic	intervention	under	investigation	was.	They	
were	randomised	and	then	the	participants	randomised	to	the	
intervention	group	were	asked	to	consent	to	having	the	trial	
intervention.[23]
An	alternative	to	individual	randomisation	is	cluster	randomisation	
where	the	trial	site	is	randomised	to	the	intervention	or	comparator.	
Cluster	randomisation	can	be	considered	where	there	is	concern	
that	the	treatment	given	to	the	control	participants	might	become	
‘contaminated’	by	the	intervention	under	evaluation.	This	may	
happen	 in	 individually	 randomised	RCTs	 if	SLTs	are	 trained	
to	deliver	the	intervention	under	evaluation	and	start	to	apply	
some	of	this	new	knowledge	to	control	participants	they	are	also	
treating.[15]	We	considered	likelihood	of	contamination	in	the	Big	
CACTUS	trial	to	be	low	and	easy	to	identify	as	the	intervention	
required	 tailoring	 of	 a	 specific	 computer	 programme,	 thus	
individual	randomisation	was	used.
How can blinding work in an aphasia trial?
Blinding	is	one	of	the	key	concepts	in	an	RCT	to	minimise	the	
likelihood	of	a	biased	outcome.	In	a	trial	of	a	new	medicine,	it	
is	possible	to	double	blind	–	i.e.,	neither	the	medic	providing	
the	medication,	nor	 the	patient	 taking	the	medication	know	
whether	they	have	been	given	the	medicine	being	trialled	or	a	
placebo.	With	aphasia	interventions,	the	SLT	and	the	person	
with	aphasia	usually	both	take	an	active	role	in	intervention	
delivery	 and	 receipt,	 and	 therefore	 cannot	 be	 blind	 to	 the	
intervention.	However,	an	alternative	way	 to	 reduce	bias	 is	
to	blind	outcome	assessors	to	the	intervention	that	has	been	
received.	The	 approach	we	 took	 in	Big	CACTUS	was	 to	
train	SLTs,	who	were	independent	from	those	who	provided	
the	 computer	word	 inding	 therapy,	 to	 carry	 out	 outcome	
measures.	As	there	is	scope	for	an	outcome	assessor	to	become	
unblind	due	to	a	colleague	SLT	and	the	participant	and	family	
members	knowing	the	intervention	group,	it	was	important	to	
report	instances	of	unblinding	so	the	success	of	the	blinding	
procedures	could	be	evaluated	and	reported.[6]
How do you choose outcome measures?
Selecting	 outcome	measures	 is	 one	 of	 the	most	 important	
considerations	when	designing	a	 trial.	We	need	 to	consider	
what	outcome	we	expect	from	the	intervention/what	people	
with	aphasia	are	hoping	to	overcome,	and	whether	there	are	
any	 validated	 outcome	measures	 available	 to	measure	 this	
outcome.	 It	 is	 important	 to	 note	 that	Wallace	et al.	 (2017)	
found	that	PWA	want	outcomes	from	therapy	that	span	the	ICF	
domains	of	impairment,	activity	and	participation.[23]	Coster	
et al.	 (2013)	 proposed	 a	 description	 for	 the	 relationship	 of	
projected	outcomes	to	the	intervention	activities,	suggesting	
that	 outcomes	 can	 be	more	 proximal	 to,	 or	more	 distal	
from	 the	 intervention	 activities.[24]	 In	 the	 Big	CACTUS	
trial,	word	 inding	was	 the	 focus	 of	 the	 intervention	with	
the	 computerised	 activities	 promoting	 practice	 of	 naming	
exercises	 in	 single	 words	 and	 sentences.	We	 therefore	
selected	 an	 impairment-based	outcome	of	 change	 in	word	
inding,	measured	 using	 a	 personalised	 naming	 test.	This	
impairment-based	measure	was	 considered	proximal	 to	 the	
intervention	 activities.	As	 the	 purpose	 of	 increasing	word	
inding	 ability	 is	 to	 improve	 functional	 communication	 in	
everyday	 contexts,	we	 also	 used	 the	 activity	 scale	 of	 the	
validated	Therapy	Outcome	Measure	 for	 aphasia	 (TOM)	
to	 assess	 videoed	 conversations	 about	 topics	 of	 interest	 to	
the	 participants.[25]	This	 outcome	was	more	distal	 from	 the	
speciic	intervention	activities.	As	the	intervention	directly	acts	
on	the	proximal	outcome	of	word	inding	in	Big	CACTUS,	
with	 the	 hypothesis	 that	 improvements	 in	 the	 proximal	
outcome	(impairment)	will	lead	to	improvements	in	the	more	
distal,	 but	 functional	 outcome	 of	 conversation	 (activity),	
both	of	these	outcomes	were	considered	equally	important	to	
measure	and	were	therefore	co-primary	outcomes.	A	range	of	
secondary	outcome	measures	were	also	used	to	measure	effects	
on	participation	and	wellbeing.[6,13]
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In	order	to	conduct	meta-analyses	of	intervention	outcomes,	
it	is	important	that	we	include	measures	to	enable	comparison	
with	other	studies	or	aggregation	of	data	from	more	than	one	
study.	Wallace	et al.	(2018)	therefore	published	a	consensus	
on	a	core	outcome	set	to	use	within	aphasia	trials.[26]
Considering the pragmatic-explanatory continuum for a 
trial of an aphasia intervention
RCTs	 can	 take	 explanatory	 or	 pragmatic	 approaches.	
Explanatory	trials	seek	to	answer	whether	an	intervention	CAN	
work	under	ideal	conditions.	Pragmatic	trials	focus	on	whether	
an	 intervention	DOES	work	 under	 usual	 conditions	 in	 the	
setting	the	intervention	is	designed	for.	Given	the	intervention	
trialled	in	Big	CACTUS	was	designed	to	enable	speech	and	
language	therapy	services	to	provide	more	therapy	to	people	
with	aphasia,	it	was	appropriate	to	take	a	pragmatic	approach	to	
see	whether	this	was	effective	when	delivered	in	routine	clinical	
practice.	The	Pragmatic-Explanatory	Continuum	 Indicator	
Summary	(PRECIS-2)	has	nine	domains	to	help	researchers	
consider	consequences	of	design	decisions	on	the	applicability	
of	results	to	usual	settings.[27]	The	application	of	these	domains	
to	Big	CACTUS	is	described	in	the	supplementary	material	to	
the	results	paper	in	the	Lancet	Neurology.[13]
Fidelity measurement considerations
It	is	important	to	measure	idelity	to	the	intervention	under	study	
in	a	trial	so	that	we	know	whether	it	was	delivered	and	received	
as	intended.	To	do	this	the	key	components	of	the	intervention	
need	to	be	well	articulated,	often	in	a	therapy	manual.	This	
can	form	the	standard	to	measure	actual	delivery	and	receipt	
against.	A	manual	was	written	for	the	intervention	trialled	in	
Big	CACTUS	 (https://www.shefield.ac.uk/polopoly_fs/1.	
525339!/ile/TherapyManual_Nov15.pdf).	The	 template	 for	
intervention	description	in	research	(TIDieR)	can	also	be	used	
to	assist	with	communicating	the	intervention	in	a	transparent	
way	 and	was	 used	 in	 the	Big	CACTUS	 results	 paper.[6,28]	
Observation	is	often	used	during	idelity	measurement.	In	Big	
CACTUS,	as	the	intervention	was	self-managed	in	participants	
own	homes,	 adherence	 to	 computer	practice	was	measured	
through	practice	data	recorded	within	the	software	used	for	
aphasia	 therapy.	Data	 collection	 forms	were	 also	 used	 to	
record	when	the	participants	received	the	software,	therapist	
decisions	in	tailoring	the	software,	support	and	contact	between	
therapists	 and	 volunteers	 and	SLT	 assistants,	 and	 support	
time	and	activities	conducted	with	participants.	The	approach	
taken	to	idelity	within	a	trial	may	relate	to	whether	the	trial	
is	 explanatory	or	pragmatic.	A	 feedback	 loop	 is	often	used	
whereby	processes	 can	be	put	 in	 place	 to	maintain	idelity	
as	much	 as	 possible	 during	 a	 trial.	This	 is	 appropriate	 in	
explanatory	trials,	to	answer	the	question	‘CAN	this	work?’.	
In	Big	CACTUS,	the	pragmatic	approach	we	took,	asking	the	
question	 ‘DOES	 this	work	 in	 usual	 settings?’	 required	 that	
we	understood	the	idelity	with	which	 the	 intervention	gets	
delivered	in	practice.	We	observed	the	idelity	with	which	the	
intervention	was	delivered	 in	practice,	however	we	did	not	
attempt	to	control	idelity	in	any	way	that	would	not	be	possible	
to	replicate	in	practice	outside	of	a	trial.[19]
CONCLUSION
This	view-point	article	outlines	some	of	the	key	decisions	that	
were	considered	during	the	Big	CACTUS	trial	of	computerised	
word	inding	therapy	in	aphasia.	This	article	is	limited	to	the	
discussion	 of	 design.	However,	 additional	 considerations	
relate	to	trial	delivery	and	reporting.	Further	perspectives	on	
considerations	and	solutions	will	be	informed	by	other	recently	
completed	and	ongoing	multicentre	aphasia	trials.
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